SPONSOR
CSL Behring
Total Trials
5
Recruiting
5
Phases
Phase 1, Phase 2, Phase 3
Conditions studied: Hemophilia BEnd Stage Kidney Disease (ESKD)Non-cystic Fibrosis BronchiectasisSecondary Immune DeficiencyComplex Cardiovascular Surgery With Cardiopulmonary Bypass
CSL Behring is a clinical research sponsor with 5 registered studies on ClinicalTrials.gov, of which 5 are actively recruiting participants. Research covers conditions including Hemophilia B, End Stage Kidney Disease (ESKD), Non-cystic Fibrosis Bronchiectasis, Secondary Immune Deficiency.
The trial portfolio spans Phase 1, Phase 2, Phase 3 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — CSL Behring
How many clinical trials has CSL Behring sponsored?
ClinicalMetric currently tracks 5 clinical trials sponsored by CSL Behring, of which 5 are actively recruiting participants. These trials cover conditions including Hemophilia B, End Stage Kidney Disease (ESKD), Non-cystic Fibrosis Bronchiectasis. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does CSL Behring research focus on?
CSL Behring clinical trials span Hemophilia B, End Stage Kidney Disease (ESKD), Non-cystic Fibrosis Bronchiectasis, Secondary Immune Deficiency, Complex Cardiovascular Surgery With Cardiopulmonary Bypass. The research pipeline includes Phase 1, Phase 2, Phase 3 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a CSL Behring clinical trial?
To participate in a CSL Behring trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all CSL Behring trials with current recruitment status updated daily.
Clinical Trials by CSL Behring
NCT06008938
Recruiting
An Observational Cohort Study to Characterize the Effectiveness and Safety of HEMGENIX® in Patients With Hemophilia B
Hemophilia B
NCT07619820 Phase 1
Recruiting
A Phase 1b Study to Evaluate the PK of CSL300 (Clazakizumab) in Chinese Subjects With End Stage Kidney Disease (ESKD)
End Stage Kidney Disease (ESKD)
NCT07048262 Phase 2
Recruiting
Dose Range Finding, Efficacy, and Safety Study of Nebulized CSL787 in Adults With Non-cystic Fibrosis Bronchiectasis (NCFB)
Non-cystic Fibrosis Bronchiectasis
NCT07648264 Phase 3
Recruiting
Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
Secondary Immune Deficiency
NCT07094087 Phase 3
Recruiting
Efficacy and Safety of 4F-PCC (4-Factor Prothrombin Complex Concentrate) in Adult Patients Undergoing Complex Cardiovascular Surgery With Cardiopulmonary Bypass (CPB)
Complex Cardiovascular Surgery With Cardiopulmonary Bypass
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology